BBC

Virtus LifeSci Biotech Clinical Trials ETF

23.92 USD
-6.15 (-20.45%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Virtus LifeSci Biotech Clinical Trials ETF stock is down -5.75% since 30 days ago. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 March’s closed higher than February.